CH415593A - Verfahren zur Herstellung von neuen Benzolsulfonylalkoxyharnstoffen - Google Patents
Verfahren zur Herstellung von neuen BenzolsulfonylalkoxyharnstoffenInfo
- Publication number
- CH415593A CH415593A CH492561A CH492561A CH415593A CH 415593 A CH415593 A CH 415593A CH 492561 A CH492561 A CH 492561A CH 492561 A CH492561 A CH 492561A CH 415593 A CH415593 A CH 415593A
- Authority
- CH
- Switzerland
- Prior art keywords
- benzenesulfonyl
- carbon atoms
- urea
- formula
- methyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000004202 carbamide Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 239000000460 chlorine Chemical group 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 229910021529 ammonia Inorganic materials 0.000 description 10
- -1 benzenesulfonyl alkoxy ureas Chemical class 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- UJYAZVSPFMJCLW-UHFFFAOYSA-N n-(oxomethylidene)benzenesulfonamide Chemical class O=C=NS(=O)(=O)C1=CC=CC=C1 UJYAZVSPFMJCLW-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000013877 carbamide Nutrition 0.000 description 7
- XYOMSHZQCMRGNN-UHFFFAOYSA-N CCCCONC(NS(C1=CC=C(C)C=C1)(=O)=O)=O Chemical compound CCCCONC(NS(C1=CC=C(C)C=C1)(=O)=O)=O XYOMSHZQCMRGNN-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- WCVVIGQKJZLJDB-UHFFFAOYSA-N o-butylhydroxylamine Chemical compound CCCCON WCVVIGQKJZLJDB-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- VLJQDHDVZJXNQL-UHFFFAOYSA-N 4-methyl-n-(oxomethylidene)benzenesulfonamide Chemical compound CC1=CC=C(S(=O)(=O)N=C=O)C=C1 VLJQDHDVZJXNQL-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HWLKXAHZLJBRNM-UHFFFAOYSA-N C1(=CC=C(C=C1)S(=O)(=O)NC(=O)NOC1CCCCC1)C Chemical compound C1(=CC=C(C=C1)S(=O)(=O)NC(=O)NOC1CCCCC1)C HWLKXAHZLJBRNM-UHFFFAOYSA-N 0.000 description 2
- PBSCOZAFBYEBAK-UHFFFAOYSA-N CCCONC(NS(C1=CC=C(C)C=C1)(=O)=O)=O Chemical compound CCCONC(NS(C1=CC=C(C)C=C1)(=O)=O)=O PBSCOZAFBYEBAK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- KYKNGOPXRHUCHC-UHFFFAOYSA-N o-cyclohexylhydroxylamine Chemical compound NOC1CCCCC1 KYKNGOPXRHUCHC-UHFFFAOYSA-N 0.000 description 2
- PRAARDGLAWZXML-UHFFFAOYSA-N o-propylhydroxylamine Chemical compound CCCON PRAARDGLAWZXML-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000001226 reprecipitation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- KLHUBDSZIPFYGP-UHFFFAOYSA-N (4-chlorophenyl)sulfonyl-methylcarbamic acid Chemical compound CN(C(O)=O)S(=O)(=O)C1=CC=C(C=C1)Cl KLHUBDSZIPFYGP-UHFFFAOYSA-N 0.000 description 1
- PHPKGFJFAMVVTI-UHFFFAOYSA-N (4-methoxyphenyl)sulfonylcarbamic acid Chemical compound COC1=CC=C(S(=O)(=O)NC(O)=O)C=C1 PHPKGFJFAMVVTI-UHFFFAOYSA-N 0.000 description 1
- OXIHBMGOHJFHII-UHFFFAOYSA-N (4-methoxyphenyl)sulfonylurea Chemical compound COC1=CC=C(S(=O)(=O)NC(N)=O)C=C1 OXIHBMGOHJFHII-UHFFFAOYSA-N 0.000 description 1
- VATAIZDYZPAXOX-UHFFFAOYSA-N (4-methylphenyl)sulfonylcarbamic acid Chemical compound CC1=CC=C(S(=O)(=O)NC(O)=O)C=C1 VATAIZDYZPAXOX-UHFFFAOYSA-N 0.000 description 1
- RUTYWCZSEBLPAK-UHFFFAOYSA-N (4-methylphenyl)sulfonylurea Chemical compound CC1=CC=C(S(=O)(=O)NC(N)=O)C=C1 RUTYWCZSEBLPAK-UHFFFAOYSA-N 0.000 description 1
- NDMSWZCITKBOIH-UHFFFAOYSA-N (4-propoxyphenyl)sulfonylcarbamic acid Chemical compound CCCOC1=CC=C(S(=O)(=O)NC(O)=O)C=C1 NDMSWZCITKBOIH-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- HEBTZZBBPUFAFE-UHFFFAOYSA-N 2-methyl-n-(oxomethylidene)benzenesulfonamide Chemical compound CC1=CC=CC=C1S(=O)(=O)N=C=O HEBTZZBBPUFAFE-UHFFFAOYSA-N 0.000 description 1
- PQWRIGCASGGXIN-UHFFFAOYSA-N 3-(4-methylphenyl)sulfonyl-1,1-diphenylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)N(C=1C=CC=CC=1)C1=CC=CC=C1 PQWRIGCASGGXIN-UHFFFAOYSA-N 0.000 description 1
- NRPHEJYDQNWSJF-UHFFFAOYSA-N 3-methyl-n-(oxomethylidene)benzenesulfonamide Chemical compound CC1=CC=CC(S(=O)(=O)N=C=O)=C1 NRPHEJYDQNWSJF-UHFFFAOYSA-N 0.000 description 1
- JGHDVROWMPBQSR-UHFFFAOYSA-N 4-chloro-n-(oxomethylidene)benzenesulfonamide Chemical compound ClC1=CC=C(S(=O)(=O)N=C=O)C=C1 JGHDVROWMPBQSR-UHFFFAOYSA-N 0.000 description 1
- ZPBSZCDTNNYFHY-UHFFFAOYSA-N 4-ethyl-n-(oxomethylidene)benzenesulfonamide Chemical compound CCC1=CC=C(S(=O)(=O)N=C=O)C=C1 ZPBSZCDTNNYFHY-UHFFFAOYSA-N 0.000 description 1
- RGVBEISMHCYSNF-UHFFFAOYSA-N 4-methoxy-n-(oxomethylidene)benzenesulfonamide Chemical compound COC1=CC=C(S(=O)(=O)N=C=O)C=C1 RGVBEISMHCYSNF-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- ILUXYYLNJNAMFH-UHFFFAOYSA-N CCCCONC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 Chemical compound CCCCONC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 ILUXYYLNJNAMFH-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical group ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 238000005773 Enders reaction Methods 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- KGINXYFISQQUQW-UHFFFAOYSA-N N-(benzenesulfonyl)carbamoyl chloride Chemical class C1(=CC=CC=C1)S(=O)(=O)NC(=O)Cl KGINXYFISQQUQW-UHFFFAOYSA-N 0.000 description 1
- CWUGNINSJRGCOH-UHFFFAOYSA-N N-[(4-chlorophenyl)sulfonylcarbamoyl]acetamide Chemical compound ClC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC(C)=O CWUGNINSJRGCOH-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000008331 benzenesulfonamides Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000035780 glucosuria Effects 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- KNVDHKOSDVFZTO-UHFFFAOYSA-N methyl n-(4-methylphenyl)sulfonylcarbamate Chemical compound COC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 KNVDHKOSDVFZTO-UHFFFAOYSA-N 0.000 description 1
- GPUWWYFDBGWKFK-UHFFFAOYSA-N n-(4-chlorophenyl)sulfonylcarbamoyl chloride Chemical compound ClC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1 GPUWWYFDBGWKFK-UHFFFAOYSA-N 0.000 description 1
- SBFRBCWEYRIGAS-UHFFFAOYSA-N n-(4-methylphenyl)sulfonylcarbamoyl chloride Chemical compound CC1=CC=C(S(=O)(=O)NC(Cl)=O)C=C1 SBFRBCWEYRIGAS-UHFFFAOYSA-N 0.000 description 1
- BGUPWXNCOACHRQ-UHFFFAOYSA-N n-propoxyaniline Chemical compound CCCONC1=CC=CC=C1 BGUPWXNCOACHRQ-UHFFFAOYSA-N 0.000 description 1
- RUMFZCKCISCDMG-UHFFFAOYSA-N o-(2-methylpropyl)hydroxylamine Chemical compound CC(C)CON RUMFZCKCISCDMG-UHFFFAOYSA-N 0.000 description 1
- BZCDKOOXCPRISF-UHFFFAOYSA-N o-(2-phenylethyl)hydroxylamine Chemical compound NOCCC1=CC=CC=C1 BZCDKOOXCPRISF-UHFFFAOYSA-N 0.000 description 1
- PXWPXXJVCQOIPH-UHFFFAOYSA-N o-(3-methylbutyl)hydroxylamine Chemical compound CC(C)CCON PXWPXXJVCQOIPH-UHFFFAOYSA-N 0.000 description 1
- XYEOALKITRFCJJ-UHFFFAOYSA-N o-benzylhydroxylamine Chemical compound NOCC1=CC=CC=C1 XYEOALKITRFCJJ-UHFFFAOYSA-N 0.000 description 1
- HWWCBAWGNJYHPP-UHFFFAOYSA-N o-cyclopentylhydroxylamine Chemical compound NOC1CCCC1 HWWCBAWGNJYHPP-UHFFFAOYSA-N 0.000 description 1
- AQTGLKJBMFAKJH-UHFFFAOYSA-N o-heptylhydroxylamine Chemical compound CCCCCCCON AQTGLKJBMFAKJH-UHFFFAOYSA-N 0.000 description 1
- AIPBDRLFQKUETL-UHFFFAOYSA-N o-hexylhydroxylamine Chemical compound CCCCCCON AIPBDRLFQKUETL-UHFFFAOYSA-N 0.000 description 1
- VBPVZDFRUFVPDV-UHFFFAOYSA-N o-pentylhydroxylamine Chemical compound CCCCCON VBPVZDFRUFVPDV-UHFFFAOYSA-N 0.000 description 1
- HLYVNXRHROOICH-UHFFFAOYSA-N o-propan-2-ylhydroxylamine Chemical compound CC(C)ON HLYVNXRHROOICH-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Chemical group 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/61—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups further bound to another hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF31115A DE1139830B (de) | 1960-04-29 | 1960-04-29 | Verfahren zur Herstellung von Benzolsulfonyl-alkoxyharnstoffen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH415593A true CH415593A (de) | 1966-06-30 |
Family
ID=7094056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH492561A CH415593A (de) | 1960-04-29 | 1961-04-26 | Verfahren zur Herstellung von neuen Benzolsulfonylalkoxyharnstoffen |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE603268A (fr) |
| CH (1) | CH415593A (fr) |
| DE (1) | DE1139830B (fr) |
| GB (1) | GB976533A (fr) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1106310B (de) | 1959-04-23 | 1961-05-10 | Bayer Ag | Verfahren zur Herstellung von Harnstoffderivaten |
-
1960
- 1960-04-29 DE DEF31115A patent/DE1139830B/de active Pending
-
1961
- 1961-04-26 GB GB1516861A patent/GB976533A/en not_active Expired
- 1961-04-26 CH CH492561A patent/CH415593A/de unknown
- 1961-05-02 BE BE603268A patent/BE603268A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1139830B (de) | 1962-11-22 |
| BE603268A (fr) | 1961-11-03 |
| GB976533A (en) | 1964-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1185180B (de) | Verfahren zur Herstellung von Benzolsulfonylharnstoffen | |
| DE2759241C3 (de) | N-(4-(2-(pyrazol-1-carbonamido)-athyl)-benzolsulfonyl) carbonide, verfahren zu ihrer herstellung und arzneimittel | |
| DE1493672B2 (de) | Verfahren zur Herstellung von Benzolsulfonylharnstoffen | |
| DE2419198C3 (de) | Benzolsulfonylharnstoffe und ihre Verwendung zur Bekämpfung von Diabetes | |
| CH415593A (de) | Verfahren zur Herstellung von neuen Benzolsulfonylalkoxyharnstoffen | |
| DE1201337B (de) | Verfahren zur Herstellung von Benzol-sulfonylharnstoffen | |
| DE2238870B2 (de) | Benzolsulfonylharnstoffe | |
| AT227715B (de) | Verfahren zur Herstellung von neuen Benzolsulfonyl-alkoxy-harnstoffen | |
| DE1181208B (de) | Verfahren zur Herstellung von N-Benzolsulfonyl-N'-cyclohexyl-harnstoffen | |
| CH370766A (de) | Verfahren zur Herstellung von oral wirksamen Antidiabetika | |
| DE2230543A1 (de) | Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung | |
| DE1518895C3 (de) | Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung | |
| AT226725B (de) | Verfahren zur Herstellung von neuen Sulfonylharnstoffen | |
| DE2000339C3 (de) | Isochinolinderivate | |
| DE1933388C (de) | l-(2-Acyl- 1,2,3,4-tetrahydroisochinolin-7sulfonyl)-harnstoffe | |
| AT216521B (de) | Verfahren zur Herstellung von neuen Benzolsulfonylharnstoffen | |
| AT212312B (de) | Verfahren zur Herstellung von neuen 2-Sulfonamidothiadiazol-Derivaten | |
| CH441274A (de) | Verfahren zur Herstellung von Benzolsulfonylharnstoffen | |
| CH427794A (de) | Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden | |
| CH438263A (de) | Verfahren zur Herstellung von Hydroxybenzolsulfonylharnstoffen | |
| AT236402B (de) | Verfahren zur Herstellung von neuen Benzolsulfonyl-semicarbaziden | |
| CH363652A (de) | Verfahren zur Herstellung von Sulfonylharnstoffen | |
| DE1668168C3 (de) | N1 substituierte N Arylsulfonyl harnstoffe, deren pharmakologisch ver fragliche Salze, Verfahren zu deren Her Stellung und diese enthaltende pharma zeutische Präparate | |
| DE1199765B (de) | Verfahren zur Herstellung von Benzolsulfonyl-harnstoffderivaten | |
| DE1076664B (de) | Verfahren zur Herstellung von neuen N-Benzolsulfonyl-N'-benzyl-harnstoffen |